Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18770828 | HANDLING OF AGE OF TRANSMITTED DATA IN MEDICAL DEVICE SYSTEM | July 2024 | September 2025 | Allow | 14 | 0 | 0 | Yes | No |
| 18762494 | SYSTEMS AND METHODS FOR RESOURCE AVAILABILITY MANAGEMENT | July 2024 | November 2025 | Allow | 16 | 0 | 0 | Yes | No |
| 18595881 | SYSTEM FOR CENTRALIZED MANAGEMENT OF ELECTRONIC DENTAL RECORDS | March 2024 | June 2025 | Abandon | 15 | 2 | 0 | No | No |
| 18202718 | A SYSTEM AND METHOD FOR SELF-ASSESSMENT OF DENTAL PROBLEMS | May 2023 | January 2026 | Abandon | 32 | 2 | 0 | No | No |
| 18036463 | SYSTEM AND METHOD TO DELIVER EMERGENCY MEDICAL SERVICES DIRECTLY TO HEALTH CARE CONSUMERS | May 2023 | January 2026 | Abandon | 33 | 2 | 0 | No | No |
| 18299051 | Methods and Systems for Predicting Risk of Cardiovascular Disease | April 2023 | September 2025 | Abandon | 29 | 1 | 0 | No | No |
| 18026879 | METHOD, DEVICE, AND COMPUTER PROGRAM FOR RECOMMENDING PRODUCT ON BASIS OF STATE OF ANIMAL | March 2023 | May 2025 | Abandon | 26 | 1 | 0 | No | No |
| 18118001 | INTEGRATED, MACHINE LEARNING POWERED, MEMBER-CENTRIC SOFTWARE AS A SERVICE (SAAS) ANALYTICS | March 2023 | September 2025 | Abandon | 30 | 2 | 0 | Yes | No |
| 18177199 | USING A GAN FOR ELECTRONIC HEALTH RECORD EXTRAPOLATION | March 2023 | December 2025 | Abandon | 34 | 2 | 0 | Yes | No |
| 18166001 | MEDICAL INFORMATION PROCESSING DEVICE, MEDICAL INFORMATION PROCESSING METHOD, AND STORAGE MEDIUM | February 2023 | February 2026 | Abandon | 36 | 3 | 0 | No | No |
| 18163411 | ADMINISTRATION SYSTEMS AND METHODS FOR USING SAME | February 2023 | September 2025 | Allow | 31 | 2 | 0 | Yes | No |
| 18005196 | HEADACHE CAUSE DETERMINATION SYSTEM, HEADACHE CAUSE DETERMINATION METHOD, PROGRAM, AND DATA STRUCTURE | January 2023 | February 2025 | Abandon | 25 | 1 | 0 | Yes | No |
| 18013664 | METHOD AND SYSTEM FOR MANAGING MEDICAL CONSULTATION CONTENT | December 2022 | August 2025 | Abandon | 31 | 2 | 0 | No | No |
| 18003356 | DETERMINING MEDICAL STAFFING FOR ORAL IMMUNOTHERAPY | December 2022 | June 2025 | Abandon | 29 | 1 | 0 | No | No |
| 18084340 | SYSTEM AND METHOD FOR PROVIDING A SURGICAL WORKFLOW TOOL | December 2022 | March 2025 | Abandon | 27 | 1 | 0 | No | No |
| 18082745 | METHODS AND SYSTEMS FOR AUTOMATIC AUTHORIZATION USING MACHINE LEARNING ALGORITHM | December 2022 | September 2025 | Abandon | 33 | 3 | 0 | Yes | No |
| 18078525 | METHOD AND SYSTEM FOR ASSESSMENT AND PREDICTING SLEEPINESS DURING OSA SCREENING USING CONSUMER DEVICES | December 2022 | July 2025 | Abandon | 31 | 2 | 0 | No | No |
| 17955700 | METHOD AND SYSTEM FOR CLINICAL TRIALS MATCHING | September 2022 | December 2025 | Abandon | 39 | 3 | 0 | No | No |
| 17932170 | BIOLOGICAL INFORMATION ACQUISITION DEVICE AND BIOLOGICAL INFORMATION ACQUISITION METHOD | September 2022 | July 2025 | Abandon | 34 | 2 | 0 | Yes | No |
| 17856106 | METHOD AND SYSTEM FOR IMPROVING PATIENT PRE-SCREENING FOR RECRUITMENT IN CLINICALS TRIALS | July 2022 | November 2024 | Abandon | 29 | 1 | 0 | No | No |
| 17827819 | METHOD AND SYSTEM FOR DETERMINING USER WELLBEING | May 2022 | April 2025 | Abandon | 34 | 2 | 0 | No | No |
| 17778919 | A SYSTEM AND METHOD FOR TRIGGERING AN ACTION BASED ON A DISEASE SEVERITY OR AFFECTIVE STATE OF A SUBJECT | May 2022 | January 2025 | Abandon | 32 | 2 | 0 | No | No |
| 17712811 | MULTIDOSE PACKAGING TARGETING SYSTEM | April 2022 | June 2024 | Allow | 27 | 1 | 0 | Yes | No |
| 17712739 | LABORATORY SAMPLE DELIVERY AND BROKER SYSTEM | April 2022 | February 2026 | Abandon | 47 | 4 | 0 | Yes | No |
| 17703061 | METHOD AND SYSTEM FOR PROVIDING PRESCRIPTION DRUG PREPARATION, DISTRIBUTION AND DELIVERY SERVICES THROUGH ELECTRONIC PRESCRIPTION | March 2022 | January 2025 | Abandon | 33 | 2 | 0 | Yes | No |
| 17595029 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND INFORMATION PROCESSING PROGRAM | November 2021 | November 2024 | Abandon | 36 | 2 | 0 | No | No |
| 17601344 | APPARATUS, SYSTEMS AND METHODS FOR PREDICTING, SCREENING AND MONITORING OF MORTALITY AND OTHER CONDITIONS UIRF 19054 | October 2021 | January 2025 | Abandon | 40 | 2 | 0 | No | No |
| 17489441 | USING MACHINE LEARNING TO ASSESS MEDICAL INFORMATION BASED ON A SPATIAL CELL ORGANIZATION ANALYSIS | September 2021 | February 2026 | Abandon | 52 | 6 | 0 | Yes | No |
| 17393816 | AUTOMATIC AND REMOTE VISUO-MECHANICS AUDITING | August 2021 | February 2025 | Allow | 43 | 3 | 1 | Yes | No |
| 17363944 | METHOD OF HUB COMMUNICATION | June 2021 | April 2025 | Allow | 45 | 4 | 0 | Yes | No |
| 17313927 | MOBILE MEDICAL SYSTEM AND METHOD | May 2021 | October 2024 | Abandon | 42 | 2 | 0 | No | No |
| 17308561 | COMPREHENSIVE DIGITAL HEALTHCARE PLATFORM | May 2021 | January 2026 | Abandon | 56 | 3 | 0 | Yes | Yes |
| 17206187 | MAPPING A PATIENT TO CLINICAL TRIALS FOR PATIENT SPECIFIC CLINICAL DECISION SUPPORT | March 2021 | January 2026 | Abandon | 58 | 4 | 0 | No | Yes |
| 17189361 | METHOD AND SYSTEM FOR ENFORCING FACILITY OCCUPANCY | March 2021 | April 2025 | Abandon | 50 | 5 | 0 | Yes | No |
| 17156256 | SYSTEMS AND METHODS FOR AN ONLINE MEDICAL PANEL | January 2021 | March 2026 | Abandon | 60 | 6 | 0 | Yes | No |
| 17056232 | DIAGNOSIS ASSISTANCE SYSTEM AND DIAGNOSIS ASSISTANCE DEVICE | January 2021 | April 2025 | Abandon | 52 | 4 | 0 | Yes | No |
| 17058014 | PERFORMING A PROGNOSTIC EVALUATION | November 2020 | August 2025 | Abandon | 57 | 6 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner CHOI, DAVID.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner CHOI, DAVID works in Art Unit 3684 and has examined 12 patent applications in our dataset. With an allowance rate of 16.7%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 52 months.
Examiner CHOI, DAVID's allowance rate of 16.7% places them in the 2% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by CHOI, DAVID receive 3.92 office actions before reaching final disposition. This places the examiner in the 97% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by CHOI, DAVID is 52 months. This places the examiner in the 4% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +28.6% benefit to allowance rate for applications examined by CHOI, DAVID. This interview benefit is in the 76% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 7.7% of applications are subsequently allowed. This success rate is in the 3% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 3% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 20% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 0.0% of appeals filed. This is in the 2% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 40% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.